No Data
No Data
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
Sen. Bernie Sanders (I-Vt.) recently expressed his concerns about the high cost of medical care in the United States, highlighting the financial burden it places on patients.
Johnson & Johnson Stock (NYSE:JNJ): The Best Buying Opportunity in Over a Decade?
Johnson & Johnson stock appears to present its most compelling buying opportunity in over a decade, following an extended period of underperformance in recent years. Despite broad indices hitting new highs, JNJ stock hasn’t gone anywhere since 2021. This lack of share price gains during this period is surprising, especially given the company’s robust results and expectations for record profits this year. This has resulted in shares trading at a highly attractive valuation. For this reason, I am bullish on its stock.
Smart Money Is Betting Big In JNJ Options
Deep-pocketed investors have adopted a bullish approach towards Johnson & Johnson (NYSE:JNJ), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga
Equity Markets Higher After Fed Chair Powell's Comments
US benchmark equity indexes were higher ahead of Monday's close after Federal Reserve Chair Jerome Powell said policymakers won't wait for inflation to fall to 2% before reducing interest rates.The
J&J (JNJ) Stock Before Q2 Earnings: To Buy or Not to Buy?
Johnson & Johnson will report its second-quarter 2024 earnings on Jul 17. The Zacks Consensus Estimate for second-quarter sales and earnings is pegged at $22.38 billion and $2.71 per share, respectively. Earnings estimates for JNJ have declined from $10.64 per share to $10.50 per share for 2024 and from $10.92 per share to $10.86 per share for 2025 over the past 60 days.
Johnson & Johnson's (NYSE:JNJ) 6.0% CAGR Outpaced the Company's Earnings Growth Over the Same Five-year Period
No Data